The Peking University Health Cohort in Anning, Yunnan (PKUHC-AN) is a prospective cohortstudy carried out in Anning, Yunnan. The primary aim of this study is to investigate theimpact of COVID-19 on older adults' health, and to provide high-quality evidence of realworld research for the optimization of prevention and control strategies of COVID-19 andother emerging infectious diseases. Data will be collected regarding health status,history of COVID-19 infections and vaccines, lifestyle and socioeconomic characteristics,as well as the short- and long-term health outcomes.
COVID-19 pandemic attributed to a great number of mortalities around the world in the
last 3 years. About 46% of the global population are estimated to have been infected by
the omicron variant and its sublineages. Health outcomes post COVID-19 has been of great
concern globally since more and more people infected by SARS-CoV-2. Integrated efforts
should be made to estimate the incidence of reinfections and long COVID in China,
especially among older adults who are vunlerable and susceptible to COVID-19. In view of
this, the Peking University Health Cohort Study in Anning, Yunnan aims to investigate the
impact of COVID-19 on older adults' health, and to provide high-quality evidence of real
world research for the optimization of prevention and control strategies of COVID-19 and
other emerging infectious diseases. Data will be collected regarding health status,
history of COVID-19 infections and vaccines, lifestyle and socioeconomic characteristics,
as well as the short- and long-term health outcomes.
Other: no interventions
This is an observational study without any intervention.
Inclusion Criteria:
-
1. ≥60 years
-
2. Resided in Anning in the past half year and have no plan to move out in next 1
year
-
3. Older adults who are willing to participate in this study with informed consent
Exclusion Criteria:
-
1. Unable to answer questions or communicate
-
2. Older adults who are not willing to participate in this study or without
informed consent
Anning medical community
Kunming, Yunan, China
Jue Liu, Ph.D, Principal Investigator
Peking University